Scarica l'app Stockscreener
76.63
0.17%
0.13
Dopo l'orario di chiusura:
76.79
0.16
+0.21%
Precedente Chiudi:
$76.50
Aprire:
$77.36
Volume 24 ore:
5.68M
Relative Volume:
0.88
Capitalizzazione di mercato:
$13.91B
Reddito:
$1.36B
Utile/perdita netta:
$-302.91M
Rapporto P/E:
-44.60
EPS:
-1.7182
Flusso di cassa netto:
$-219.93M
1 W Prestazione:
-9.86%
1M Prestazione:
+23.72%
6M Prestazione:
+61.70%
1 anno Prestazione:
-14.19%
Intervallo 1D:
$75.80
$80.31
Intervallo di 1 settimana:
$75.80
$89.09
Portata 52W:
$40.77
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Nome
Tempus Ai Inc
Settore
Industria
Telefono
800-976-5448
Indirizzo
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, TXG, BTSG, HNGE
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
76.63 | 15.43B | 1.36B | -302.91M | -219.93M | -1.7182 |
VEEV
Veeva Systems Inc
|
273.33 | 45.44B | 3.32B | 941.65M | 1.64B | 5.6161 |
TXG
10 X Genomics Inc
|
93.50 | 11.17B | 638.78M | -22.66M | 122.18M | -0.1744 |
BTSG
Brightspring Health Services Inc
|
60.25 | 11.20B | 13.65B | 169.86M | 412.12M | 1.0758 |
HNGE
Hinge Health Inc
|
97.67 | 7.71B | 646.34M | -512.40M | 202.76M | -6.6871 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-13 | Iniziato | Jefferies | Underperform |
| 2026-04-13 | Aggiornamento | TD Cowen | Hold → Buy |
| 2026-02-19 | Iniziato | Mizuho | Outperform |
| 2026-02-17 | Iniziato | Robert W. Baird | Outperform |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-10-21 | Downgrade | TD Cowen | Buy → Hold |
| 2025-10-20 | Iniziato | Canaccord Genuity | Buy |
| 2025-09-02 | Iniziato | H.C. Wainwright | Buy |
| 2025-04-21 | Iniziato | BTIG Research | Buy |
| 2025-02-25 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-02-12 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-02-05 | Ripresa | TD Cowen | Buy |
| 2024-12-13 | Iniziato | Wolfe Research | Outperform |
| 2024-12-09 | Iniziato | Guggenheim | Buy |
| 2024-11-11 | Downgrade | Stifel | Buy → Hold |
| 2024-10-02 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-08-12 | Iniziato | Piper Sandler | Neutral |
| 2024-07-09 | Iniziato | BofA Securities | Buy |
| 2024-07-09 | Iniziato | JP Morgan | Overweight |
| 2024-07-09 | Iniziato | Longbow | Buy |
| 2024-07-09 | Iniziato | Loop Capital | Buy |
| 2024-07-09 | Iniziato | Morgan Stanley | Overweight |
| 2024-07-09 | Iniziato | Needham | Buy |
| 2024-07-09 | Iniziato | Stifel | Buy |
| 2024-07-09 | Iniziato | TD Cowen | Buy |
| 2024-07-09 | Iniziato | William Blair | Outperform |
Mostra tutto
Tempus Ai Inc Borsa (TEM) Ultime notizie
Tempus AI (NASDAQ:TEM) Shares Down 6.1%Here's Why - MarketBeat
Tempus Announces 13 Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2026 - Business Wire
What Does Today’s Signal Mean for Tempus AI (NASDAQ:TEM)? - Kalkine Media
$Tempus AI (TEM.US)$ - Moomoo
A trading plan governed the sale of 10,281 Tempus AI (TEM) shares by its diagnostics CEO at $85 each. - Stock Titan
Tempus AI, Inc. Class A Bonds — Corporate Bond Rates - TradingView
Why Tempus AI (TEM) Stock Is Down Today - Quiver Quantitative
Best Artificial Intelligence Stocks To ConsiderSeptember 29th - MarketBeat
Current ratio of Tempus AI, Inc. Class A – HAN:F3M - TradingView
Tempus AI Has Three FDA-Cleared ECG Algorithms - FourWeekMBA
Tempus AI receives FDA clearance for heart valve AI tool - Investing.com
Tempus AI receives FDA clearance for heart valve AI tool By Investing.com - Investing.com India
Tempus Receives FDA Clearance for its ECG-MR AI Product Designed to Identify Undiagnosed Mitral Regurgitation - Business Wire
Cathie Wood's Ark Invest weekly recap: boosts Meta, Rocket Lab; cuts Tempus AI, CrowdStrike (ARKK:BATS) - Seeking Alpha
Tempus AI CEO Ryan Fukushima sells $49,000 in stock By Investing.com - Investing.com South Africa
Tempus AI CEO Lefkofsky sells $16.1m common stock By Investing.com - Investing.com South Africa
Tempus AI CEO Lefkofsky sells $16.1m common stock - Investing.com
Tempus AI CEO Ryan Fukushima sells $49,000 in stock - Investing.com
Tempus AI CAO Ryan Bartolucci sells $529,650 in stock - Investing.com
Form 4 Tempus AI Inc For: 27 September By Investing.com - Investing.com Canada
Tempus AI EVP Andrew Polovin sells 2,951 shares for $221,325 - Investing.com
Form 144 Tempus AI For: 27 September - Investing.com India
Artificial Intelligence Stocks To Watch TodaySeptember 26th - MarketBeat
Tempus AI gets FDA clearance for pulmonary hypertension AI tool - scanx.trade
Tempus AI, Inc. Class A Ignites Investor Hype - TipRanks
Form 144 Tempus AI For: 26 September - Investing.com India
Form 144 Tempus AI For: 26 September By Investing.com - Investing.com Australia
Artificial Intelligence Stocks To Follow TodaySeptember 25th - MarketBeat
Tempus AI, Inc. (TEM) options chain - Yahoo Finance Australia
Tempus AI, Inc. (TEM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Leica Biosystems brings Tempus pathology products to Aperio AI Store, accelerating AI-powered capabilities for oncology research - News-Medical
AI in Clinical Trials Market Set for Transformative Growth Through 2040, Unlocking Opportunities Across Trial Phases, Therapeutic Areas, End Users and Key Global Regions - GlobeNewswire Inc.
#Day 10Looking to Take Profit on my tempus - Moomoo
Tempus AI (NASDAQ:TEM) CEO Sells 250,000 Shares of Company Stock - MarketBeat
RXRX Stock Rises As Tempus AI Deal Resets Growth Story - StocksToTrade
Tempus AI(TEM.US) 10% Shareholder Sells US$19.37 Million in Common Stock - moomoo.com
Tempus AI CEO-linked entities sell 250,000 shares - Stock Titan
Tempus AI Inc Stock (TEM) Closed Up by 7.38% on Sep 24: What Investors Need To Know - TradingKey
Tempus AI (NASDAQ:TEM) Trading 6.1% HigherTime to Buy? - MarketBeat
Tempus AI Soars As Wall Street Bets On Data - TipRanks
Promising Artificial Intelligence Stocks To ConsiderSeptember 24th - MarketBeat
Tempus AI Chief Accounting Officer Sells $529,650 of Stock - The Globe and Mail
Buy 3 AI-Powered Medical Stocks to Strengthen Your Portfolio in Q4 - finance.yahoo.com
Cathie Wood’s ARK sells Tempus AI stock, buys Scribe Therapeutics By Investing.com - Investing.com South Africa
Cathie Wood’s ARK sells Tempus AI stock, buys Scribe Therapeutics - Investing.com
Tempus AI (TEM) Has a $75 Goldman Sachs Target, But Its Data Business Faces a Bigger Test - Yahoo Finance
Tempus AI Stock Price: TEM Stock Chart, Market Cap & News Today - CoinGecko
Tempus AI (NASDAQ:TEM) Upgraded by The Goldman Sachs Group to Hold Rating - MarketBeat
Tempus AI: High Risk, But With A Great Cause (NASDAQ:TEM) - Seeking Alpha
Goldman Sachs initiates coverage of Tempus AI (TEM.US) with a Neutral rating: Diagnostic business to benefit from reimbursement tailwinds, while data contracts enter a "validation phase" - moomoo.com
Tempus AI: Data And Applications Will Unlock More Upside (NASDAQ:TEM) - Seeking Alpha
Tempus Ai Inc Azioni (TEM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.34%
0.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):